yarqtqeowcxkpclggsxklspceopqacbiqapieses length 5 51110 page 51110 <!DOCTYPE html>
<html  lang="en" dir="ltr" prefix="og: https://ogp.me/ns#">
  <head>
    <meta charset="utf-8" />
<link rel="canonical" href="https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" />
<script type="application/json">{"utility":"piwik","siteID":"109","sitePath":["www.ema.europa.eu"],"siteSection":"covid-19","instance":"europa.eu"}</script>
<script type="application/json">{"utility":"cck","url":"\/about-us\/about-website\/cookies"}</script>
<meta name="Generator" content="Drupal 10 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script type="application/ld+json">{
          "@context": "https://schema.org",
          "@type": "BreadcrumbList",
          "itemListElement": [{
            "@type": "ListItem",
            "position": "1",
            "name": "Home",
            "item": "https://www.ema.europa.eu/en/homepage"
          },{
            "@type": "ListItem",
            "position": "2",
            "name": "News",
            "item": "https://www.ema.europa.eu/en/news"
          },{
              "@type": "ListItem",
              "position": "3",
              "name": "AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets"
            }]}</script>
<link rel="icon" href="/themes/custom/ema_theme/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" hreflang="en" href="https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" />
<script type="text/javascript">window.MSInputMethodContext && document.documentMode && document.write("\u003Clink rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.ema.europa.eu\/themes\/contrib\/oe_bootstrap_theme\/assets\/css\/bootstrap-ie11.css\u0022\u003E\u003Cscript src=\u0022https:\/\/cdn.jsdelivr.net\/combine\/npm\/ie11-custom-properties@4,npm\/element-qsa-scope@1\u0022\u003E\u003C\/script\u003E\u003Cscript crossorigin=\u0022anonymous\u0022 src=\u0022https:\/\/polyfill.io\/v3\/polyfill.min.js?features=default%2CNumber.parseInt%2CNumber.parseFloat%2CArray.prototype.find%2CArray.prototype.includes\u0022\u003E\u003C\/script\u003E");</script>

    <title>AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets | European Medicines Agency</title>
    <link rel="stylesheet" media="all" href="/sites/default/files/css/css_sd7rDB84LnUObw7Xq06OgPNO2R_Pi2zNBbfCOCxafXM.css?delta=0&amp;language=en&amp;theme=ema_theme&amp;include=eJx1j0F2wyAMRC9kwqrn4Ql7EtMAopJI6tuX2Em7SZ9W8zV6mkGhMF-xJGP58CjkFrIxMUOnIcPCcy-oduyewhm7irtrdMHuumRWJdlCI1GIf8MmRrgjGnNWv0hvlE8v7bSQWGZahk83NRQfSbHfrMmQKSJ7tS3vLDKbmlALtqLAxzm_w4f_keXQjwo7G9W-Lad6fQV5yknI4Hu9scGtyG3E2dHdndMNaiTTzAKfqkHqOPz86pDtdGYp0-hJl_F9_e33R069th5z0hXLpCCZ10AtBerGM5eWMb78w38AC8Wk-Q" />
<link rel="stylesheet" media="all" href="/sites/default/files/css/css_gQBUsV41bugLMLyFviazh0mxICkO0nGuDfAjHp8Dr6A.css?delta=1&amp;language=en&amp;theme=ema_theme&amp;include=eJx1j0F2wyAMRC9kwqrn4Ql7EtMAopJI6tuX2Em7SZ9W8zV6mkGhMF-xJGP58CjkFrIxMUOnIcPCcy-oduyewhm7irtrdMHuumRWJdlCI1GIf8MmRrgjGnNWv0hvlE8v7bSQWGZahk83NRQfSbHfrMmQKSJ7tS3vLDKbmlALtqLAxzm_w4f_keXQjwo7G9W-Lad6fQV5yknI4Hu9scGtyG3E2dHdndMNaiTTzAKfqkHqOPz86pDtdGYp0-hJl_F9_e33R069th5z0hXLpCCZ10AtBerGM5eWMb78w38AC8Wk-Q" />

    
  </head>
  <body class="context-ema_content_banner context-ema_general_search context-ema_sitewide path--node-85602 path-node page-node-type-ema-news">
    <a href="#main-content" class="visually-hidden focusable skip-link">
      Skip to main content
    </a>
    <script type="application/json">{"utility":"globan","theme":"dark","logo":true,"link":true,"mode":false}</script>

      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    <div data-ema-glossary-ct="ema_news" class="ema-glossary-enabled page"><header class="bcl-header bcl-header--neutral"><nav
   class="w-100 shadow-sm navbar navbar-expand-lg navbar-light"
><div class='container'><a  class="navbar-brand" href="/en/homepage" alt="Home - European Medicines Agency" title="Home - European Medicines Agency"><img src="/themes/custom/ema_theme/resources/images/logo_ema.svg" alt="European Medicines Agency's logo" title="European Medicines Agency"/></a><div class="ema-search-form"><a class="ema-search-icon" href="https://www.ema.europa.eu/search"><svg
   class="bi icon--s"
><use xlink:href="/themes/contrib/oe_bootstrap_theme/assets/icons/bcl-default-icons.svg#search"/></svg></a><div class="ema-search-form-wrapper"><form action="/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" method="post" id="oe-whitelabel-search-form" accept-charset="UTF-8" class="oe-whitelabel-search-form inline-form"><div class="js-form-item form-item js-form-type-search-api-autocomplete form-item-search-input js-form-item-search-input form-no-label"><label for="edit-search-input" class="visually-hidden form-label">Search</label><input placeholder="" data-drupal-selector="edit-search-input" data-search-api-autocomplete-search="ema_search" class="form-autocomplete form-control" data-autocomplete-path="/en/search_api_autocomplete/ema_search?display=ema_search_page&amp;filter=search_api_fulltext" type="text" id="edit-search-input" name="search_input" value="" size="20" maxlength="500" /><span class="ico"></span></div><div class="form-actions"><input data-drupal-selector="edit-submit" type="submit" id="edit-submit--3" name="op" value="Search" class="button js-form-submit form-submit btn-primary btn" /><span class="ico"></span></div><input autocomplete="off" data-drupal-selector="form-xmw1qkjylbx42cu4fjbnfafk31n9i-jzbt0vnwxkqiy" type="hidden" name="form_build_id" value="form-Xmw1qkjyLBx42Cu4fjbnFAfk31N9i_JZbt0vnwxkqiY" class="form-control" /><input data-drupal-selector="edit-oe-whitelabel-search-form" type="hidden" name="form_id" value="oe_whitelabel_search_form" class="form-control" /><input data-drupal-selector="edit-ema-search-url" type="hidden" name="ema_search_url" value="https://www.ema.europa.eu/search" class="form-control" /></form></div></div></div></nav><div class="bcl-header__project light"><div class="container"></div></div><nav
   class="bcl-header__navbar navbar navbar-expand-lg navbar-dark"
><div class='container'><button
      class="navbar-toggler"
      type="button"
      data-bs-toggle="collapse"
      data-bs-target='#bcl-navbar--2'
      aria-controls='bcl-navbar--2'
      aria-expanded="false"
      aria-label="Toggle navigation"
    ><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id='bcl-navbar--2'><h2 class="visually-hidden" id="block-system-menu-block-main-menu">Main navigation</h2><ul
     class="me-auto navbar-nav"
  ><li
          class="nav-item dropdown"
                  ><a href="/en/medicines" class="nav-link dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-804" role="button" data-drupal-link-system-path="node/73303">Medicines</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-804"
  ><li><a href="/en/medicines" class="dropdown-item" data-drupal-link-system-path="node/73303">Find medicine</a></li><li><a href="/en/medicines/therapeutic-areas-latest-updates" class="dropdown-item" data-drupal-link-system-path="node/68943">Therapeutic areas: latest updates</a></li><li><a href="/en/medicines/download-medicine-data" class="dropdown-item" data-drupal-link-system-path="node/82422">Download</a></li><li><a href="/en/medicines/what-we-publish-medicines-and-when" class="dropdown-item" data-drupal-link-system-path="node/82426">What we publish on medicines and when</a></li><li><a href="/en/medicines/medicines-human-use-under-evaluation" class="dropdown-item" data-drupal-link-system-path="node/68492">Medicines under evaluation</a></li><li><a href="/en/medicines/national-registers-authorised-medicines" class="dropdown-item" data-drupal-link-system-path="node/70104">National registers</a></li></ul></li><li
          class="nav-item dropdown"
                  ><a href="/en/human-regulatory-overview" class="nav-link dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-274" role="button" data-drupal-link-system-path="node/82389">Human regulatory</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-274"
  ><li><a href="/en/human-regulatory-overview" class="dropdown-item" data-drupal-link-system-path="node/82389">Overview</a></li><li><a href="/en/human-regulatory-overview/research-development" class="dropdown-item" data-drupal-link-system-path="node/69491">Research and development</a></li><li><a href="/en/human-regulatory-overview/marketing-authorisation" class="dropdown-item" data-drupal-link-system-path="node/69601">Marketing authorisation</a></li><li><a href="/en/human-regulatory-overview/post-authorisation" class="dropdown-item" data-drupal-link-system-path="node/70358">Post-authorisation</a></li><li><a href="/en/human-regulatory-overview/medical-devices" class="dropdown-item" data-drupal-link-system-path="node/70079">Medical devices</a></li><li><a href="/en/human-regulatory-overview/herbal-medicinal-products" class="dropdown-item" data-drupal-link-system-path="node/69717">Herbal products</a></li></ul></li><li
          class="nav-item dropdown"
                  ><a href="/en/veterinary-regulatory-overview" class="nav-link dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-297" role="button" data-drupal-link-system-path="node/82419">Veterinary regulatory</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-297"
  ><li><a href="/en/veterinary-regulatory-overview" class="dropdown-item" data-drupal-link-system-path="node/82419">Overview</a></li><li><a href="/en/veterinary-regulatory-overview/research-development-veterinary-medicines" class="dropdown-item" data-drupal-link-system-path="node/69449">Research and development</a></li><li><a href="/en/veterinary-regulatory-overview/marketing-authorisation-veterinary-medicines" class="dropdown-item" data-drupal-link-system-path="node/69313">Marketing authorisation</a></li><li><a href="/en/veterinary-regulatory-overview/post-authorisation-veterinary-medicines" class="dropdown-item" data-drupal-link-system-path="node/68838">Post-authorisation</a></li></ul></li><li
          class="nav-item dropdown"
                  ><a href="/en/committees" class="nav-link dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-296" role="button" data-drupal-link-system-path="node/82424">Committees</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-296"
  ><li><a href="/en/committees" class="dropdown-item" data-drupal-link-system-path="node/82424">Overview</a></li><li><a href="/en/committees/how-committees-work" class="dropdown-item" data-drupal-link-system-path="node/68348">How the committees work</a></li><li><a href="/en/committees/committee-medicinal-products-human-use-chmp" class="dropdown-item" data-drupal-link-system-path="node/4879">CHMP</a></li><li><a href="/en/committees/committee-veterinary-medicinal-products-cvmp" class="dropdown-item" data-drupal-link-system-path="node/4882">CVMP</a></li><li><a href="/en/committees/pharmacovigilance-risk-assessment-committee-prac" class="dropdown-item" data-drupal-link-system-path="node/4886">PRAC</a></li><li><a href="/en/committees/committee-orphan-medicinal-products-comp" class="dropdown-item" data-drupal-link-system-path="node/4881">COMP</a></li><li><a href="/en/committees/committee-herbal-medicinal-products-hmpc" class="dropdown-item" data-drupal-link-system-path="node/4883">HMPC</a></li><li><a href="/en/committees/committee-advanced-therapies-cat" class="dropdown-item" data-drupal-link-system-path="node/4878">CAT</a></li><li><a href="/en/committees/paediatric-committee-pdco" class="dropdown-item" data-drupal-link-system-path="node/4885">PDCO</a></li><li><a href="/en/committees/working-parties-other-groups" class="dropdown-item" data-drupal-link-system-path="node/69598">Working parties and other groups</a></li></ul></li><li
          class="nav-item dropdown"
                  ><a href="/en/news-and-events" class="nav-link active dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-636" role="button" data-drupal-link-system-path="node/82423">News &amp; events</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-636"
  ><li><a href="/en/news-and-events" class="dropdown-item" data-drupal-link-system-path="node/82423">Overview</a></li><li><a href="/en/news" class="active dropdown-item" data-drupal-link-system-path="node/4">News</a></li><li><a href="/en/events/upcoming-events" class="dropdown-item" data-drupal-link-system-path="node/8">Events</a></li><li><a href="/en/news-events/whats-new" class="dropdown-item" data-drupal-link-system-path="news-events/whats-new">What&#039;s new</a></li><li><a href="/en/news-and-events/committee-highlights" class="dropdown-item" data-drupal-link-system-path="node/68454">Committee highlights</a></li><li><a href="/en/news-and-events/publications" class="dropdown-item" data-drupal-link-system-path="node/69163">Publications</a></li><li><a href="/en/news-and-events/press-social-media" class="dropdown-item" data-drupal-link-system-path="node/70061">Press and social media</a></li><li><a href="/en/news-and-events/open-consultations" class="dropdown-item" data-drupal-link-system-path="node/10">Open consultations</a></li><li><a href="/en/news-and-events/rss-feeds" class="dropdown-item" data-drupal-link-system-path="node/4876">RSS feeds</a></li></ul></li><li
          class="nav-item dropdown"
                  ><a href="/en/partners-networks" class="nav-link dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-101" role="button" data-drupal-link-system-path="node/82420">Partners &amp; networks</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-101"
  ><li><a href="/en/partners-networks" class="dropdown-item" data-drupal-link-system-path="node/82420">Overview</a></li><li><a href="/en/partners-networks/eu-partners" class="dropdown-item" data-drupal-link-system-path="node/69559">EU partners</a></li><li><a href="/en/partners-networks/international-activities" class="dropdown-item" data-drupal-link-system-path="node/69859">International activities</a></li><li><a href="/en/partners-networks/patients-consumers" class="dropdown-item" data-drupal-link-system-path="node/69035">Patients and consumers</a></li><li><a href="/en/partners-networks/healthcare-professionals" class="dropdown-item" data-drupal-link-system-path="node/69297">Healthcare professionals</a></li><li><a href="/en/partners-networks/pharmaceutical-industry" class="dropdown-item" data-drupal-link-system-path="node/69655">Pharmaceutical industry</a></li><li><a href="/en/partners-networks/networks" class="dropdown-item" data-drupal-link-system-path="node/68770">Networks</a></li><li><a href="/en/partners-networks/health-technology-assessment-bodies" class="dropdown-item" data-drupal-link-system-path="node/68799">Health technology assessment bodies</a></li></ul></li><li
          class="nav-item dropdown"
                  ><a href="/en/about-us" class="nav-link dropdown-toggle" aria-expanded="false" data-bs-toggle="dropdown" id="dropdown-287" role="button" data-drupal-link-system-path="node/82421">About us</a><ul
     class="dropdown-menu" aria-labelledby="dropdown-287"
  ><li><a href="/en/about-us" class="dropdown-item" data-drupal-link-system-path="node/82421">Overview</a></li><li><a href="/en/about-us/what-we-do" class="dropdown-item" data-drupal-link-system-path="node/69654">What we do</a></li><li><a href="/en/about-us/who-we-are" class="dropdown-item" data-drupal-link-system-path="node/69649">Who we are</a></li><li><a href="/en/about-us/how-we-work" class="dropdown-item" data-drupal-link-system-path="node/69885">How we work</a></li><li><a href="/en/about-us/fees-payable-european-medicines-agency" class="dropdown-item" data-drupal-link-system-path="node/70027">Fees</a></li><li><a href="/en/about-us/support-smes" class="dropdown-item" data-drupal-link-system-path="node/69589">Support to SMEs</a></li><li><a href="/en/about-us/annual-reports-work-programmes" class="dropdown-item" data-drupal-link-system-path="node/70025">Annual reports and work programmes</a></li><li><a href="/en/about-us/history-ema" class="dropdown-item" data-drupal-link-system-path="node/68954">History of EMA</a></li><li><a href="/en/about-us/careers" class="dropdown-item" data-drupal-link-system-path="node/69992">Careers</a></li><li><a href="/en/about-us/procurement" class="dropdown-item" data-drupal-link-system-path="node/69872">Procurement</a></li><li><a href="/en/about-us/glossaries" class="dropdown-item" data-drupal-link-system-path="node/5">Glossaries</a></li><li><a href="/en/about-us/about-website" class="dropdown-item" data-drupal-link-system-path="node/70271">About this website</a></li><li><a href="/en/about-us/data-protection-privacy" class="dropdown-item" data-drupal-link-system-path="node/68881">Data protection and privacy</a></li><li><a href="/en/about-us/contacts-european-medicines-agency" class="dropdown-item" data-drupal-link-system-path="node/68696">Contacts</a></li></ul></li></ul></div></div></nav><div class="container"><div id="block-system-breadcrumb-block"><nav
   class="my-2-5" aria-label="breadcrumb"
><ol
    class="breadcrumb"
  ><li
        class="breadcrumb-item d-none d-md-block"
        
      ><a href="/en/homepage">Home</a></li><li
        class="breadcrumb-item"
        
      ><a href="https://www.ema.europa.eu/en/news"><svg
   class="d-md-none ms-0 me-2 me-2-5 bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#arrow-left"/></svg>News</a></li><li
        class="breadcrumb-item d-none d-md-block active"
        aria-current="page"
      >AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets</li></ol></nav></div></div></header><main id="main-content" class="main-content-wrapper"><div class="container mt-3"><div class="row"><div class="col-12"><div data-drupal-messages-fallback class="hidden"></div><div id="block-ema-content-banner--2"><div class="node ema-news content-banner ema-news--content-banner mb-4-75 bcl-content-banner ema-light-blue"><div class="container px-0"><div class="row"><div class="col-12"><article class="bg-transparent border-0 card container"><div class="row"><div class="right-col"><div class="card-body container"><div class="row"><div class="col"><div class="heading-title"><h1 class="content-banner-title card-title bcl-heading"><span>AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets</span></h1></div><div class="heading-actions align-self-stretch d-flex justify-content-end"><div class="action-bar"><div class="ecl-social-media-share"><script type="application/json">{"service":"share","selection":true,"stats":true,"css":{"button":"btn btn-default ema-share-button"},"target":true}</script><svg
   class="bi icon--xs"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#share-fill"/></svg></div></div></div><div class="card-content-block"><div class="card-content-wrapper"><div class="meta-items"><span class="text-muted"><div class="field datetime ema-news__field-ema-public-date"><time datetime="2021-04-07T15:45:00Z">7 April 2021</time></div></span></div></div><div class="card-badge-wrapper"><span class="bundle-name badge rounded-pill bg-primary" title="News"><span class="label">News</span></span><span class="ema-bg-category badge rounded-pill badge-outline-primary" title="Human"><span class="label">Human</span></span><span class="ema-bg-topic special-topic badge rounded-pill bg-covid" title="COVID-19"><span class="label">COVID-19</span></span><span class="ema-bg-topic badge rounded-pill badge-outline-primary" title="Vaccines"><span class="label">Vaccines</span></span></div></div></div></div></div></div></div></article></div></div></div></div></div></div><div class="col-12 "><div class="row"><div class="col-12"><div id="block-system-main-block" class="main-content"><article class="content-without-sidebar node ema-news ema-news--full container"><div class="ema-node-content-wrapper node-sections"><div  class="item"><div id="ema-inpage-item-43960" class="paragraph paragraph--type--oe-rich-text paragraph--view-mode--default"><div class="ecl-editor"><h4>EMA confirms overall benefit-risk remains positive</h4><p>EMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).</p><p>In reaching its conclusion, the committee took into consideration all currently available evidence, including the advice from an ad hoc expert group.</p><p>EMA is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination. So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.</p><p>People who have received the vaccine should seek medical assistance immediately if they develop symptoms of this combination of blood clots and low blood platelets (see below).</p><p>The PRAC noted that the blood clots occurred in veins in the brain (cerebral venous sinus thrombosis, CVST) and the abdomen (splanchnic vein thrombosis) and in arteries, together with low levels of blood platelets and sometimes bleeding.</p><p>The Committee carried out an in-depth review of 62 cases of cerebral venous sinus thrombosis and 24 cases of splanchnic vein thrombosis reported in the EU drug safety database (EudraVigilance) as of 22 March 2021, 18 of which were fatal.<sup>1</sup>&nbsp;The cases came mainly from spontaneous reporting systems of the EEA and the UK, where around 25 million people had received the vaccine.</p><p>COVID-19 is associated with a risk of hospitalisation and death. The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.</p><p>EMA’s scientific assessment underpins the safe and effective use of COVID-19 vaccines. Use of the vaccine during vaccination campaigns at national level will also take into account the pandemic situation and vaccine availability in the individual Member State.</p><p>One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin (heparin induced thrombocytopenia, HIT). The PRAC has requested new studies and amendments to ongoing ones to provide more information and will take any further actions necessary.</p><p>The PRAC stresses the importance of prompt specialist medical treatment. By recognising the signs of bloods clots and low blood platelets and treating them early, healthcare professionals can help those affected in their recovery and avoid complications.</p><div class="table-responsive"><div class="table-responsive"><table style="width:100%;" class="table"><tbody><tr><td style="background-color: rgb(255, 255, 255);"><h4>Patients should seek medical assistance immediately if they have the following symptoms</h4><ul><li>shortness of breath</li><li>chest pain</li><li>swelling in your leg</li><li>persistent abdominal (belly) pain</li><li>neurological symptoms, including severe and persistent headaches or blurred vision</li><li>tiny blood spots under the skin beyond the site of injection</li></ul></td></tr></tbody></table></div></div><ul></ul><p>Vaxzevria is one of four vaccines authorised in the EU for protecting against COVID-19. Studies show that it is effective at preventing the disease. It also reduces the risk of hospitalisation and deaths from COVID-19.</p><p>As for all vaccines, EMA will continue to monitor the vaccine’s safety and effectiveness and provide the public with the latest information.</p><h4>Information for the general public</h4><ul><li>Cases of unusual blood clots with low platelets have occurred in people who received Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).</li><li>The chance of having this occur is very low, but you should still be aware of symptoms so you can get prompt medical treatment to help recovery and avoid complications.</li><li>You must seek urgent medical attention immediately if you have any of the following symptoms in the weeks after your injection:
<ul><li>shortness of breath</li><li>chest pain</li><li>leg swelling</li><li>persistent abdominal (belly) pain</li><li>neurological symptoms, such as severe and persistent headaches or blurred vision</li><li>tiny blood spots under the skin beyond the site of the injection.</li></ul></li><li>Speak to your healthcare professional or contact your relevant national health authorities if you have any questions about the roll out of the vaccine in your country.</li></ul><h4>Information for healthcare professionals</h4><ul><li>EMA has reviewed cases of thrombosis in combination with thrombocytopenia, and in some cases bleeding, in people who received Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).</li></ul><ul><li>These very rare types of thrombosis (with thrombocytopenia) included venous thrombosis in unusual sites such as cerebral venous sinus thrombosis and splanchnic vein thrombosis as well as arterial thrombosis. Most of the cases reported so far have occurred in women under the age of 60 years. Most cases occurred within 2 weeks of the person receiving their first dose. There is limited experience with the second dose.</li><li>As for the mechanism, it is thought that the vaccine may trigger an immune response leading to an atypical heparin-induced-thrombocytopenia like disorder. At this time, it is not possible to identify specific risk factors.</li><li>Healthcare professionals should be alert to the signs and symptoms of thromboembolism and thrombocytopenia so that they can promptly treat people affected in line with available guidelines.</li><li>Healthcare professionals should tell people receiving the vaccine that they must seek medical attention if they develop:
<ul><li>symptoms of blood clots such as shortness of breath, chest pain, leg swelling, persistent abdominal pain</li><li>neurological symptoms such as severe and persistent headaches and blurred vision</li><li>petechiae beyond the site of vaccination after a few days.</li></ul></li><li>The benefits of the vaccine continue to outweigh the risks for people who receive it. The vaccine is effective at preventing COVID-19 and reducing hospitalisations and deaths.</li><li>National authorities may provide additional guidance on the roll out of the vaccine based on the situation in your country.</li></ul><p>Healthcare professionals involved in giving the vaccine in the EU will receive a direct healthcare professional communication (DHPC). The DHPC will also be <a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="65d21982-30bb-4741-bda5-d5bd8a2348f5" href="/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/direct-healthcare-professional-communications" title="Direct healthcare professional communications">available</a>.</p><h4>More about the medicine</h4><p>Vaxzevria (formerly COVID-19 Vaccine AstraZeneca) is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older. COVID-19 is caused by SARS-CoV-2 virus. COVID-19 Vaccine AstraZeneca is made up of another virus (of the adenovirus family) that has been modified to contain the gene for making a protein from SARS-CoV-2. The vaccine does not contain the virus itself and cannot cause COVID-19.</p><p>The most common side effects are usually mild or moderate and improve within a few days after vaccination.</p><h4>More about the procedure</h4><p>This review was carried out in the context of a&nbsp;safety signal, under an accelerated timetable. A&nbsp;safety signal&nbsp;is information on a new or incompletely documented&nbsp;adverse event&nbsp;that is potentially caused by a medicine such as a vaccine and that warrants further investigation.</p><p>The review was carried out by EMA's&nbsp;Pharmacovigilance Risk Assessment Committee&nbsp;(PRAC), the Committee responsible for the evaluation of safety issues for human medicines. EMA’s human medicine committee,&nbsp;CHMP, will now rapidly assess any necessary changes to the&nbsp;product information.</p><p>EMA’s scientific assessment underpins the safe and effective use of COVID-19 vaccines. EMA’s recommendations are the foundation upon which individual EU Member States will design and implement their own national vaccination campaigns. These may differ from country to country depending on their national needs and circumstances, such as infection rates, priority populations, vaccine availability and hospitalisation rates.</p><hr><p><sup>1 </sup>As of 4 April 2021, a total of 169 cases of CVST and 53 cases of splanchnic vein thrombosis were reported to EudraVigilance. Around 34 million people had been vaccinated in the EEA and UK by this date. The more recent data do not change the PRAC’s recommendations.</p></div></div></div><div  class="item"><div class="related-section-wrapper" id="ema-inpage-item-58040"><h4 id="related-content-58040" class="rounded-title d-flex align-items-center p-2 mb-3"><span class="title flex-grow-1">
          Related content
        </span><span class="icon"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#"/></svg></span></h4><div  class="item"><div id="ema-inpage-item-51111" class="paragraph paragraph--type--oe-rich-text paragraph--view-mode--related-section"><div class="ecl-editor"><ul><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="23823f13-7f64-43d0-a366-944d1373c3bf" href="/en/events/press-briefing-conclusion-assessment-pharmacovigilance-risk-assessment-committee-prac-vaxzevria-previously-covid-19-vaccine-astrazeneca-and-thromboembolic-events" title="Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events">Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events</a>&nbsp;(07/04/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="5ee523db-0365-4d12-8b26-df406645c548" href="/en/news/astrazeneca-covid-19-vaccine-review-very-rare-cases-unusual-blood-clots-continues" title="AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues">AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues</a>&nbsp;(30/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="e482f629-4519-4b51-96f1-053910eb9f8c" href="/en/news/covid-19-vaccine-astrazeneca-update-ongoing-evaluation-blood-clot-cases" title="COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases">COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases</a>&nbsp;(25/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="9416b39b-34eb-4fe8-971e-1f44e5f5cdc8" href="/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots-low-blood-platelets" title="COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets">COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets</a>&nbsp;(18/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="b7864ec6-a533-4e57-984c-cd678c334999" href="/en/news/investigation-covid-19-vaccine-astrazeneca-and-thromboembolic-events-continues" title="Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues">Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues</a>&nbsp;(16/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="ba8edb7d-6f5b-42ba-8f78-68eb678b99a2" href="/en/news/emas-safety-committee-continues-investigation-covid-19-vaccine-astrazeneca-thromboembolic-events-further-update" title="EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update">EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update</a>&nbsp;(15/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="9a8bf88f-d222-4dff-b9f6-9df2a280be1a" href="/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits-currently-still-outweigh-risks-update" title="COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update">COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update</a>&nbsp;(11/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="ae320a47-974f-4072-8710-23328a9c3f94" href="/en/news/covid-19-vaccine-astrazeneca-prac-preliminary-view-suggests-no-specific-issue-batch-used-austria" title="COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria">COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria</a>&nbsp;(10/03/2021)</li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="9c7e3eba-2f13-462e-8626-6a001536cda3" href="/en/medicines/dhpc/vaxzevria-previously-covid-19-vaccine-astrazeneca" title="Vaxzevria (previously COVID-19 Vaccine AstraZeneca)">Direct healthcare professional communication (DHPC):&nbsp;COVID-19 Vaccine AstraZeneca: Risk of thrombocytopenia and coagulation disorders</a></li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="39809186-b268-4d1b-8556-8395c65a84f1" href="/en/covid-19-vaccines-authorised" title="COVID-19 vaccines: authorised">COVID-19 vaccines: authorised</a></li><li><a data-entity-substitution="canonical" data-entity-type="node" data-entity-uuid="9d34c9df-10ff-47b9-8431-4a10eaf49330" href="/en/outdated-pharmacovigilance-risk-assessment-committee-prac" title="OUTDATED Pharmacovigilance Risk Assessment Committee (PRAC)">Pharmacovigilance Risk Assessment Committee (PRAC)</a></li></ul></div></div></div></div></div><div  class="item"><div class="related-section-wrapper" id="ema-inpage-item-58041"><h4 id="contact-point-58041" class="rounded-title d-flex align-items-center p-2 mb-3"><span class="title flex-grow-1">
          Contact point
        </span><span class="icon"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#"/></svg></span></h4><div  class="item"><div id="ema-inpage-item-51112" class="paragraph paragraph--type--oe-rich-text paragraph--view-mode--related-section"><div class="ecl-editor"><p><strong>EMA press office</strong><br />Tel. +31 (0)88 781 8427<br />E-mail: <a href="mailto:press@ema.europa.eu">press@ema.europa.eu</a><br />Follow us on Twitter <a href="https://twitter.com/EMA_News">@EMA_News</a></p></div></div></div></div></div><div id="ema-inpage-item-related-medicines" data-section="related-medicines" class="section related-medicines"><h4 id="related-medicines" class="mb-3 rounded-title">Related content</h4><div class="field ema-news__field-ema-ne-related-content multiple"><ul class="field__items"><li class="field__item"><a href="/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca" hreflang="en">Vaxzevria (previously COVID-19 Vaccine AstraZeneca)</a></li></ul></div></div><div class="ecl-social-media-share mb-4"><h2>Share this page</h2><script type="application/json">{"service":"share","popup":false,"selection":true,"to":["more","e-mail","facebook","twitter","whatsapp"]}</script></div></div><div class="rate-widget fivestar"><form class="node-ema-news-85602-fivestar-ema-page-rating-0 vote-form" id="rate-widget-base-form" data-drupal-selector="node-ema-news-85602-fivestar-ema-page-rating-0" action="/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets" method="post" accept-charset="UTF-8"><div class="ema-rating-widget-block full-width py-4-5 d-none"><div class="container"><div class="row"><div class="col-12"><h3 class="mb-4-5">How useful do you find this page?</h3><div class="ema-rating-wrapper"><div class="ema-rating-form"><div class="fivestar-rating-wrapper rate-enabled" can-edit="true"><div class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none"  style="display:none"><label class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none rating-label fivestar-rating-label fivestar-rating-label-1 stars star-1 average"><span class="form-item"><input twig-suggestion="rating-input" class="rating-input fivestar-rating-input fivestar-rating-input-1 form-radio form-check-input" data-drupal-selector="edit-value-1" type="radio" id="edit-value-1" name="value" value="1" /></span><span class="form-label">1</span></label></div><div class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none"  style="display:none"><label class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none rating-label fivestar-rating-label fivestar-rating-label-2 stars star-2"><span class="form-item"><input twig-suggestion="rating-input" class="rating-input fivestar-rating-input fivestar-rating-input-2 form-radio form-check-input" data-drupal-selector="edit-value-2" type="radio" id="edit-value-2" name="value" value="2" /></span><span class="form-label">2</span></label></div><div class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none"  style="display:none"><label class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none rating-label fivestar-rating-label fivestar-rating-label-3 stars star-3"><span class="form-item"><input twig-suggestion="rating-input" class="rating-input fivestar-rating-input fivestar-rating-input-3 form-radio form-check-input" data-drupal-selector="edit-value-3" type="radio" id="edit-value-3" name="value" value="3" /></span><span class="form-label">3</span></label></div><div class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none"  style="display:none"><label class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none rating-label fivestar-rating-label fivestar-rating-label-4 stars star-4"><span class="form-item"><input twig-suggestion="rating-input" class="rating-input fivestar-rating-input fivestar-rating-input-4 form-radio form-check-input" data-drupal-selector="edit-value-4" type="radio" id="edit-value-4" name="value" value="4" /></span><span class="form-label">4</span></label></div><div class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none"  style="display:none"><label class="form-item js-form-item form-type-radio js-form-type-radio form-item-value js-form-item-value d-none rating-label fivestar-rating-label fivestar-rating-label-5 stars star-5"><span class="form-item"><input twig-suggestion="rating-input" class="rating-input fivestar-rating-input fivestar-rating-input-5 form-radio form-check-input" data-drupal-selector="edit-value-5" type="radio" id="edit-value-5" name="value" value="5" /></span><span class="form-label">5</span></label></div></div><input autocomplete="off" data-drupal-selector="form-2dnen5r3z73jrvuqvpuqc4gydpl8j-2tolezyoevlqo" type="hidden" name="form_build_id" value="form-2Dnen5r3z73JRVuQvPuQC4gYdpL8j-2tOLeZyOevLQo" class="form-control" /><input data-drupal-selector="edit-node-ema-news-85602-fivestar-ema-page-rating-0" type="hidden" name="form_id" value="node_ema_news_85602_fivestar_ema_page_rating_0" class="form-control" /><input class="fivestar-rating-submit button button--primary js-form-submit form-submit btn-primary btn" data-drupal-selector="edit-submit" data-disable-refocus="true" type="submit" id="edit-submit--2" name="op" value="Save" /></div><div class="ema-rating-summary"><div class="vote-result js-form-wrapper form-wrapper" data-drupal-selector="edit-result" id="edit-result"><div class="ema-rating-average d"><span class="label">Average:</span></div></div></div></div></div></div></div></div></form></div></article></div></div></div></div></div></div></main><div id="block-ema-footer-block"><footer  class="ema-footer text-white bcl-footer bcl-footer--neutral"><div class="container"><div class="ema-footer-product-hotline row"><div class="col-12"><div class="border"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#telephone-fill"/></svg><a href="/en/about-us/contacts-european-medicines-agency" class="ema-footer-eu-agencies" target="_blank" hreflang="en"><p class="product-hotline-title">Product emergency hotline</p><p class="product-hotline-information">OUTSIDE WORKING HOURS</p></a></div></div></div><div class="ema-footer-footer-links row"><div class="col-12 col-md-6 col-lg-3 footer-links"><div class="link d-block"><a class="standalone" href="/en/about-us">About us</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/what-we-do">What we do</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/careers">Careers</a></div><div class="link d-block"><a class="standalone" href="/en/committees">Committees &amp; working parties</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/how-we-work/european-medicines-regulatory-network">Regulatory network</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/how-we-work/european-medicines-regulatory-network/european-experts">European experts</a></div></div><div class="col-12 col-md-6 col-lg-3 footer-links"><div class="link d-block"><a class="standalone" href="/en/about-us/about-website/languages-website">Languages</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/frequently-asked-questions">Frequently asked questions</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/glossaries">Glossaries</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/about-website">About this website</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/data-protection-privacy">Privacy</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/about-website/cookies">Cookies</a></div></div><div class="col-12 col-md-6 col-lg-3 footer-links"><div class="link d-block"><a class="standalone" href="/en/about-us/about-website/search-tips">Search tips</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/how-we-work/access-documents">Access to documents</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/contacts-european-medicines-agency">Contacts</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/contacts-european-medicines-agency/send-question-european-medicines-agency">Send a question</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/contacts-european-medicines-agency">EMA Service Desk (system support)</a></div><div class="link d-block"><a class="standalone" href="/en/about-us/how-we-work/services-databases">Services and databases</a></div></div><div class="col-12 col-md-6 col-lg-3 ema-footer--footer-contact"><p>European Medicines Agency<br>Domenico Scarlattilaan&nbsp;6<br>1083 HS Amsterdam<br>The Netherlands</p><p>Tel: +31 (0)88 781 6000</p><p><a href="/about-us/contacts-european-medicines-agency/how-find-us" data-entity-type="node" data-entity-uuid="4b93fc56-414f-4edc-85a1-62989537c1b9" data-entity-substitution="canonical">How to find us</a><br><a href="/about-us/contacts-european-medicines-agency/how-find-us#addresses-6923" data-entity-type="node" data-entity-uuid="4b93fc56-414f-4edc-85a1-62989537c1b9" data-entity-substitution="canonical">Postal address and deliveries</a><br><a href="/about-us/contacts-european-medicines-agency/business-hours-holidays" data-entity-type="node" data-entity-uuid="7cac129c-d271-4ead-854a-ed65cdb60ddc" data-entity-substitution="canonical">Business hours and holidays</a></p></div></div><div class="ema-footer-social-media-links row"><div class="col-12 social-media-links-wrapper"><ul class="social-links-list"><li class="list-item"><a href="/news-event/rss-feeds" class="link standalone" target="_blank"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#rss"/></svg>
          RSS Feed
        </a></li><li class="list-item"><a href="https://twitter.com/EMA_News" class="link standalone" target="_blank"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#twitter"/></svg>
          Twitter
        </a></li><li class="list-item"><a href="https://www.youtube.com/user/emainfo" class="link standalone" target="_blank"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#youtube"/></svg>
          YouTube
        </a></li><li class="list-item"><a href="https://www.linkedin.com/company/european-medicines-agency/" class="link standalone" target="_blank"><svg
   class="bi icon--s"
><use xlink:href="/themes/custom/ema_theme/resources/icons/ema-bcl-bootstrap-icons.svg#linkedin"/></svg>
          LinkedIn
        </a></li></ul></div></div><div class="ema-footer-footer-agencies row"><div class="col-12 col-md-12 col-lg-4 bottom-links medicines-agency"><a href="https://www.ema.europa.eu/" class="ema-footer__copyright">    © 1995 - 2024 European Medicines Agency
  </a></div><div class="col-12 col-md-6 col-lg-4 bottom-links agencies-network"><a href="https://euagencies.eu/" class="ema-footer__eu_agencies" target="_blank">    European Union agencies network
    <span class="logo"></span></a></div><div class="col-12 col-md-6 col-lg-4 bottom-links eu"><a href="https://european-union.europa.eu/" class="ema-footer__eu_agencies" target="_blank">    An agency of the European Union
    <span class="logo"></span></a></div></div></div></footer></div></div>
  </div>

    
    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","pathPrefix":"en\/","currentPath":"node\/85602","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"eJx1Tkt2wyAMvJCJVz2Pn7AnNg0gKom4vn0IddpN-rSar2ZmwRiyQTLFy-dXhRyXK0sakGiab1iCsXyMDbmFrJ2P0C4uPNeEbD_aCZyxy9hdoRXdtUZWJTmmQqKQ8Q3XfbYhoVepHf3Ft8WQb-MitbRpJxwYk2c2NaFyhvwc39G95yns8MYc9VX1wk4TiUWmpW14-rZgiOQRz2ybR2sr3H6jf8yl5lJ9DLphGYQMY813NrgNsbS-Tu3uGu5QIxkUJPM2UQkTVeOZU4loln_4QQ81pNGT4gH4PKT5","theme":"ema_theme","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true,"\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets?ajax_form=1":true},"ema_document":{"base_url":"\/documents\/"},"ema_glossary_parser":{"json_uri":"https:\/\/www.ema.europa.eu\/sites\/default\/files\/glossary_parser\/1714863637.json"},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":false,"extNofollow":true,"extNoreferrer":false,"extFollowNoOverride":false,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":false,"extExclude":"","extInclude":"","extCssExclude":".bcl-featured-media, .bcl-fact-figures, .bcl-listing, .ema-subscribe-button","extCssExplicit":"main","extAlert":false,"extAlertText":"This link will take you to an external web site. We are not responsible for their content.","mailtoClass":"0","mailtoLabel":"(link sends email)","extUseFontAwesome":false,"extIconPlacement":"append","extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","whitelistedDomains":[]}},"ajax":{"edit-submit--2":{"disable-refocus":true,"callback":"::ajaxSubmit","event":"click","wrapper":"rate-widget-base-form","progress":{"type":null},"url":"\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets?ajax_form=1","httpMethod":"POST","dialogType":"ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Save"}}},"search_api_autocomplete":{"ema_search":{"auto_submit":true,"min_length":3}},"user":{"uid":0,"permissionsHash":"83248faf50f9f6d992722127945255bccda51742c9f31c062c3bebf14506539c"}}</script>
<script src="/sites/default/files/js/js_mIsNlq8wfzdMi3iL7u6hhw-Sk2C_8ThyjQg-wF8eIeU.js?scope=footer&amp;delta=0&amp;language=en&amp;theme=ema_theme&amp;include=eJx1j0F2wyAMRC9kwqrn4Ql7EtMAopJI6tuX2Em7SZ9W8zV6mkGhMF-xJGP58CjkFrIxMUOnIcPCcy-oduyewhm7irtrdMHuumRWJdlCI1GIf8MmRrgjGnNWv0hvlE8v7bSQWGZahk83NRQfSbHfrMmQKSJ7tS3vLDKbmlALtqLAxzm_w4f_keXQjwo7G9W-Lad6fQV5yknI4Hu9scGtyG3E2dHdndMNaiTTzAKfqkHqOPz86pDtdGYp0-hJl_F9_e33R069th5z0hXLpCCZ10AtBerGM5eWMb78w38AC8Wk-Q"></script>
<script src="https://europa.eu/webtools/load.js" defer></script>
<script src="/sites/default/files/js/js_3z7yPDV8MvimdafUPbdd_XU9n11RKMMB3z58xGwKZ64.js?scope=footer&amp;delta=2&amp;language=en&amp;theme=ema_theme&amp;include=eJx1j0F2wyAMRC9kwqrn4Ql7EtMAopJI6tuX2Em7SZ9W8zV6mkGhMF-xJGP58CjkFrIxMUOnIcPCcy-oduyewhm7irtrdMHuumRWJdlCI1GIf8MmRrgjGnNWv0hvlE8v7bSQWGZahk83NRQfSbHfrMmQKSJ7tS3vLDKbmlALtqLAxzm_w4f_keXQjwo7G9W-Lad6fQV5yknI4Hu9scGtyG3E2dHdndMNaiTTzAKfqkHqOPz86pDtdGYp0-hJl_F9_e33R069th5z0hXLpCCZ10AtBerGM5eWMb78w38AC8Wk-Q"></script>

  </body>
</html>
 contentType 9 text/html url 147 https://www.ema.europa.eu:443/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood-platelets responseCode 3 200 